BR112022004462A2 - Métodos para melhorar a fusão espinhal com abaloparatida - Google Patents

Métodos para melhorar a fusão espinhal com abaloparatida

Info

Publication number
BR112022004462A2
BR112022004462A2 BR112022004462A BR112022004462A BR112022004462A2 BR 112022004462 A2 BR112022004462 A2 BR 112022004462A2 BR 112022004462 A BR112022004462 A BR 112022004462A BR 112022004462 A BR112022004462 A BR 112022004462A BR 112022004462 A2 BR112022004462 A2 BR 112022004462A2
Authority
BR
Brazil
Prior art keywords
abaloparatide
spinal fusion
methods
spinal
subject
Prior art date
Application number
BR112022004462A
Other languages
English (en)
Inventor
Klara Maria Mannstadt Beate
Bruce Mitlak
Original Assignee
Radius Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radius Health Inc filed Critical Radius Health Inc
Publication of BR112022004462A2 publication Critical patent/BR112022004462A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/29Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/46Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2/4601Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for introducing bone substitute, for implanting bone graft implants or for compacting them in the bone cavity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2002/2817Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cardiology (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

métodos para melhorar a fusão espinhal com abaloparatida. são providos neste documento métodos para intensificar a fusão espinhal e a formação óssea em indivíduos com fraturas espinhais, deformidades ou instabilidade na coluna. o método inclui a administração (por exemplo, por via subcutânea ou transdérmica) de uma quantidade terapeuticamente eficaz de abaloparatida ao indivíduo. em um aspecto, é provido neste documento um método para intensificar a fusão espinhal, incluindo a administração a um indivíduo com fratura espinhal, uma quantidade terapeuticamente eficaz de abaloparatida, de modo que a fusão espinhal seja intensificada no indivíduo.
BR112022004462A 2019-09-12 2020-09-14 Métodos para melhorar a fusão espinhal com abaloparatida BR112022004462A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962899633P 2019-09-12 2019-09-12
PCT/US2020/050729 WO2021051082A1 (en) 2019-09-12 2020-09-14 Methods of improving spinal fusion with abaloparatide

Publications (1)

Publication Number Publication Date
BR112022004462A2 true BR112022004462A2 (pt) 2022-05-31

Family

ID=74866536

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022004462A BR112022004462A2 (pt) 2019-09-12 2020-09-14 Métodos para melhorar a fusão espinhal com abaloparatida

Country Status (7)

Country Link
US (1) US20220193203A1 (pt)
EP (1) EP4027899A4 (pt)
CN (1) CN114364327A (pt)
BR (1) BR112022004462A2 (pt)
CL (2) CL2022000590A1 (pt)
MX (1) MX2022002979A (pt)
WO (1) WO2021051082A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS49707B (sr) * 1997-09-09 2007-12-31 F.Hoffmann-La Roche Ag., Primena polipeptidnog analoga peptida srodnog paratireoidnom hormonu i njegovih soli za proizvodnju medikamenata za lečenje preloma kostiju
WO2005038453A1 (en) * 2003-10-17 2005-04-28 Medvet Science Pty Ltd Early assessment of motor recovery in spinal cord injury patients
WO2016141250A1 (en) * 2015-03-03 2016-09-09 Radius Health, Inc. USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
PL3359241T3 (pl) * 2015-10-09 2021-12-20 Radius Health, Inc. Formulacje analogów pthrp, plastry przezskórne je zawierające i ich zastosowania

Also Published As

Publication number Publication date
WO2021051082A1 (en) 2021-03-18
CN114364327A (zh) 2022-04-15
MX2022002979A (es) 2022-06-16
EP4027899A4 (en) 2023-08-16
CL2022000590A1 (es) 2022-11-11
US20220193203A1 (en) 2022-06-23
CL2023001017A1 (es) 2023-12-11
EP4027899A1 (en) 2022-07-20

Similar Documents

Publication Publication Date Title
BR112017024461A2 (pt) “usos de nuc-1031 e método para determinar se um paciente com câncer ou uma condição pré-cancerosa se beneficiará de prevenção ou tratamento de câncer com o mesmo”.
BR112015004362A2 (pt) conjunto de fixação intramedular
BR112020015915A8 (pt) Usos de um anticorpo anti-pd-1 e um anticorpo anti-ctla4 ou fragmentos de ligação ao antígeno dos mesmos, bem como kit para tratamento de um paciente com câncer
BR112017022653A2 (pt) ?métodos para o tratamento ou para a prevenção de uma doença, da artrite reumatoide, da prostatite e da bph?
BR112022020643A2 (pt) Método de tratamento de esteato-hepatite não alcoólica
EP4137147A3 (en) Uses of abaloparatide in reducing fracture risk
BR112016013961A2 (pt) angiotensina ii sozinha ou em combinação para o tratamento da hipotensão
BR112017022755A2 (pt) formulações de glucopiranosil lipídeo a e alérgeno a amendoim para administração sublingual
BR112022000710A2 (pt) Vacina viral terapêutica
BR112018000079A2 (pt) dispositivo de fixação externa dinâmica de osteossíntese
BR112022004462A2 (pt) Métodos para melhorar a fusão espinhal com abaloparatida
BR112018074496A2 (pt) composição biopesticida para uso na prevenção minimização de doenças de plantas
BR112015022025A8 (pt) composição e uso de um agente ativo
BR112019008516A2 (pt) derivado de 3,4-bipiridil pirazol, e método de preparação para o mesmo e aplicação médica do mesmo
BR102020023560A8 (pt) Composições e métodos para tratar os olhos
BR112017027298A2 (pt) método de tratamento e/ou prevenção de drea ou asma em pacientes humanos; e método de prevenção, reversão ou tratamento de sintoma(s) de dessensibilização à aspirina em pacientes com drea
BR112017025839A2 (pt) tratamento de doenças mitocondriais
BR112021026775A2 (pt) Processo para preparar uma composição que compreende um polipeptídeo de proteína d
BR112017001146A2 (pt) terapia com anticorpo anti-vegfr2 para carcinoma hepatocelular
MD3744G2 (ro) Dispozitiv şi metodă de determinare a locului abordului chirurgical în fracturile arcadei zigomatice
Shimbaretskiy LEADING ROLE OF KINEZOTHERAPY IN REHABILITATION OF PATIENTS AFTER OSTEOSYNTHESIS WITH APPLICATION OF MODERN CONSTRUCTIONS
Anand et al. Study of Morphometry of clavicle–Length and Angles
UA114664U (uk) Спосіб лікування неправильно консолідованих переломів вилицевого комплексу
BR112022006267A2 (pt) Método para tratar hiv com cabotegravir e rilpivirina
ZA202100897B (en) Composition for improved bone fracture healing